Aspirin for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jan 2019: Trial registered, NCT03819101
  2. 6 Jun 2019: Trial started, NCT03819101

The trials

NCT03819101: Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

State
Under way
Phase
Phase 3
People
1,210 planned
Started
6 Jun 2019
Primary completion
Mar 2042
Arms
Arm B
Results
None posted
  1. 28 Jan 2019: Trial registered
  2. 6 Jun 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Asa, Aspirin 100mg, Aspirin 100mg for 1-month (immediately after PCI), Aspirin 100mg for 6-month (6-month post PCI), Clopidogrel/acetylsalicylic acid component aspirin, CoPRIME aspirin alone, Duocover component aspirin, Duoplavin component aspirin, Durlaza, Measurin, Yosprala component aspirin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.